Cargando…
Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study
OBJECTIVES: The study aims at investigating the influence of several factors on the probability of receiving one of the two tiotropium formulations (Respimat or Handihaler). DESIGN: Drug utilisation study. SETTING: All residents in the Region Umbria, Italy, aged ≥45 years, who received prescriptions...
Autores principales: | Trotta, Francesco, Da Cas, Roberto, Rajevic, Maja, Rossi, Mariangela, Traversa, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452750/ https://www.ncbi.nlm.nih.gov/pubmed/26009573 http://dx.doi.org/10.1136/bmjopen-2014-006619 |
Ejemplares similares
-
Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study
por: Trotta, Francesco, et al.
Publicado: (2017) -
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
por: Anzueto, Antonio, et al.
Publicado: (2015) -
Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
por: Rau-Berger, Heike, et al.
Publicado: (2010) -
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015) -
Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies
por: Bateman, Eric, et al.
Publicado: (2010)